FBP2 | Fructose-1,6-bisphosphatase 2 | Enzymes Plasma proteins
| | | | | Tissue enriched |
LSMEM2 | Leucine-rich single-pass membrane protein 2 | Predicted membrane proteins
| | | | | Group enriched |
PLCD4 | Phospholipase C, delta 4 | Enzymes
| | | | | Tissue enriched |
RTN2 | Reticulon 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
SCN4A | Sodium channel, voltage-gated, type IV, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
ALPK3 | Alpha-kinase 3 | Enzymes
| | | | | Group enriched |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
CAV3 | Caveolin 3 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
COX7A1 | Cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | | | | Group enriched |
LRRC2 | Leucine rich repeat containing 2 | | | | | | Group enriched |
MAPK12 | Mitogen-activated protein kinase 12 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
MLF1 | Myeloid leukemia factor 1 | Cancer-related genes Disease related genes
| | | | | Group enriched |
MURC | Muscle-related coiled-coil protein | | | | | | Group enriched |
MYOD1 | Myogenic differentiation 1 | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
MYOG | Myogenin (myogenic factor 4) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enriched |
MYOM3 | Myomesin 3 | | | | | | Group enriched |
NKAIN1 | Na+/K+ transporting ATPase interacting 1 | Predicted membrane proteins
| | | | | Group enriched |
PITX3 | Paired-like homeodomain 3 | Disease related genes Transcription factors
| | | | | Tissue enriched |
RGS9BP | Regulator of G protein signaling 9 binding protein | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
RXRG | Retinoid X receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enriched |
SH3BGR | SH3 domain binding glutamic acid-rich protein | | | | | | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SRPK3 | SRSF protein kinase 3 | Enzymes
| | | | | Group enriched |
TXLNB | Taxilin beta | | | | | | Group enriched |
C1orf167 | Chromosome 1 open reading frame 167 | | | | | | Group enriched |
CAND2 | Cullin-associated and neddylation-dissociated 2 (putative) | | | | | | Group enriched |
CKM | Creatine kinase, muscle | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
KBTBD12 | Kelch repeat and BTB (POZ) domain containing 12 | | | | | | Group enriched |
LMO1 | LIM domain only 1 (rhombotin 1) | Cancer-related genes Disease related genes
| | | | | Group enriched |
MAFA | V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A | Transcription factors
| | | | | Group enriched |
MYBPH | Myosin binding protein H | | | | | | Group enriched |
MYH7B | Myosin, heavy chain 7B, cardiac muscle, beta | | | | | | Group enriched |
NT5C1A | 5'-nucleotidase, cytosolic IA | Enzymes
| | | | | Group enriched |
POPDC3 | Popeye domain containing 3 | Predicted membrane proteins
| | | | | Group enriched |
RP11-155D18.14 | Poly(rC)-binding protein 4 | | | | | | Tissue enriched |
RP5-966M1.6 | Musculoskeletal embryonic nuclear protein 1 | | | | | | Group enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
TAL2 | T-cell acute lymphocytic leukemia 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
TMEM52 | Transmembrane protein 52 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
TPM2 | Tropomyosin 2 (beta) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
UPK3A | Uroplakin 3A | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACTA1 | Actin, alpha 1, skeletal muscle | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enriched |
ASB15 | Ankyrin repeat and SOCS box containing 15 | | | | | | Group enriched |
C20orf26 | Chromosome 20 open reading frame 26 | Predicted membrane proteins
| | | | | Group enriched |
CACNB1 | Calcium channel, voltage-dependent, beta 1 subunit | FDA approved drug targets
| | | | | Tissue enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CARNS1 | Carnosine synthase 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
COQ10A | Coenzyme Q10 homolog A (S. cerevisiae) | Mitochondrial proteins
| | | | | Group enriched |